The expression of transforming growth factor β receptor 2 (TGFBR2), a tumor suppressor, is downregulated in head and neck squamous cell cancer (HNSCC) (Chu et al., 2013) and is generally related to EMT in LSCC (Lu et al., 2006). This evidence concerns the gene TGFBR2 and neoplasm.